Literature DB >> 5580838

Liver scintigrams compared with alkaline phosphatase and BSP determinations in the detection of metastatic carcinoma.

S G Jhingran, L Jordan, M F Jahns, T P Haynie.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 5580838

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


× No keyword cloud information.
  9 in total

1.  The uses and limitations of radioisotopes in the investigation of gastrointestinal diseases.

Authors:  P Braunstein; C S Song
Journal:  Am J Dig Dis       Date:  1975-01

2.  The role of radionuclide imaging in disease of the alimentary tract.

Authors:  L M Freeman; L Rosenthall
Journal:  Gastrointest Radiol       Date:  1976

3.  Case report: Liver scintigraphy in the follow-up of a patient on cytotoxic therapy.

Authors:  H P Breuel; F Douwes; M Bähre; T San Luis; D Emrich
Journal:  Eur J Nucl Med       Date:  1976-12-30

4.  Liver function tests in patients with computed tomography demonstrated hepatic metastases.

Authors:  M D Ottmar; R L Gonda; K J Leithauser; O H Gutierrez
Journal:  Gastrointest Radiol       Date:  1989

Review 5.  Progress report. Ultrasound and gastroenterology.

Authors:  F R Vicary
Journal:  Gut       Date:  1977-05       Impact factor: 23.059

6.  Benefits and risks in nuclear medicine.

Authors:  P C Johnson
Journal:  Am J Public Health       Date:  1972-12       Impact factor: 9.308

Review 7.  Hepatic radionuclide imaging: an effective diagnostic procedure!

Authors:  M A Rothschild
Journal:  Am J Dig Dis       Date:  1976-08

8.  Computerized tomography and nuclear imaging of the liver: a comparative study in 83 cases.

Authors:  U Scherer; U Büll; R Rothe; J Eisenburg; F W Schildberg; P Meister; J Lissner
Journal:  Eur J Nucl Med       Date:  1978-04-01

9.  Screening for liver metastases from colorectal cancer with carcinoembryonic antigen and alkaline phosphatase.

Authors:  P I Tartter; G Slater; I Gelernt; A H Aufses
Journal:  Ann Surg       Date:  1981-03       Impact factor: 12.969

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.